Relationship between the Use of Inhaled Steroids for Chronic Respiratory Diseases and Early Outcomes in Community-Acquired Pneumonia

• Jordi Almirall ,

  * E-mail: jalmirall@csdm.cat

  Affiliation Critical Care Unit, Universitat Autònoma de Barcelona, CIBERES, Barcelona, Spain

  ⨯
• Ignasi Bolíbar,

  Affiliation Department of Clinical Epidemiology and Public Health, Institute of Biomedical Research (IIB Sant Pau) Barcelona, Universitat Autònoma de Barcelona, Ciber de Epidemiología y Salud Pública (CIBERESP)

  ⨯
• Mateu Serra-Prat,

  Affiliation Research Unit, Hospital de Mataró, CIBEREHD, Barcelona

  ⨯
• Elisabet Palomera,

  Affiliation Research Unit, Hospital de Mataró, CIBEREHD, Barcelona

  ⨯
• Jordi Roig,

  Affiliation Hospital Nostra Senyora de Meritxell, Principat d’Andorra

  ⨯
• Imma Hospital,

  Affiliation Institut Català de la Salut (ICS), Basrcelona

  ⨯
• Eugenia Carandell,

  Affiliation IB-SALUT Balears, Palma de Mallorca

  ⨯
• Mercè Agustí,

  Affiliation Institut Català de la Salut (ICS), Basrcelona

  ⨯
• Pilar Ayuso,

  Affiliation INSALUD, Valencia, Spain

  ⨯
• Andreu Estela,

  Affiliation IB-SALUT Balears, Palma de Mallorca

  ⨯
• Antoni Torres,

  Affiliation Servei de Pneumologia, Institut Clínic del Torax, IDIBAPS, Hospital Clínic de Barcelona, Universitat de Barcelona, CIBERES, Barcelona, Spain

  ⨯
• and the Community-Acquired Pneumonia in Catalan Countries (PACAP)

  ¶Members of the PACAP Study Group can be found in the acknowledgments

  ⨯